BioCentury
ARTICLE | Company News

Ex-Juno execs launch cell therapy start-up Sana

January 11, 2019 5:55 PM UTC

Former Juno Therapeutics Inc. executives Steve Harr and Hans Bishop launched Sana Biotechnology Inc. (Seattle, Wash.) on Jan. 4 with the goal of aggregating R&D and manufacturing capabilities across the cell and gene therapy treatment paradigms.

Harr, who was CFO and head of corporate development at Juno, will be Sana's CEO. Former Juno President and CEO Bishop will be the start-up's chairman...